Abstract
Adult hepatocyte transplantation is limited by scarce availability of suitable donor liver tissue for hepatocyte isolation. New cell-based therapies are being developed to supplement whole-organ liver transplantation, to reduce the waiting-list mortality rate, and to obtain more sustained and significant metabolic correction. Fetal livers and unsuitable neonatal livers for organ transplantation have been proposed as potential useful sources of hepatic cells for cell therapy. However, the major challenge is to use alternative cell sources for transplantation that can be derived from reproducible methods. Different types of stem cells with hepatic differentiation potential are eligible for generating large numbers of functional hepatocytes for liver cell therapy to treat degenerative disorders, inborn hepatic metabolic diseases, and organ failure. Clinical trials are designed to fully establish the safety profile of such therapies and to define target patient groups and standardized protocols.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dhawan A, Puppi J, Hughes RD, Mitry RR (2010) Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7:288–298
Fisher RA, Strom SC (2006) Human hepatocyte transplantation: worldwide results. Transplantation 82:441–449
Fitzpatrick E, Mitry RR, Dhawan A (2009) Human hepatocyte transplantation: state of the art. J Intern Med 266:339–357
Forbes SJ, Gupta S, Dhawan A (2015) Cell therapy for liver disease: from liver transplantation to cell factory. J Hepatol 62:S157–S169
Hansel MC, Gramignoli R, Skvorak KJ, Dorko K, Marongiu F, Blake W, Davila J, Strom SC (2014) The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients. Curr Protoc Toxicol 62:14 12 11–14 12 23
Jorns C, Ellis EC, Nowak G, Fischler B, Nemeth A, Strom SC, Ericzon BG (2012) Hepatocyte transplantation for inherited metabolic diseases of the liver. J Intern Med 272:201–223
Pietrosi G, Vizzini GB, Gruttadauria S, Gridelli B (2009) Clinical applications of hepatocyte transplantation. World J Gastroenterol 15:2074–2077
Puppi J, Strom SC, Hughes RD, Bansal S, Castell JV, Dagher I et al (2012) Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 21:1–10
Bonora-Centelles A, Donato MT, Lahoz A, Pareja E, Mir J, Castell JV, Gomez-Lechon MJ (2010) Functional characterization of hepatocytes for cell transplantation: customized cell preparation for each receptor. Cell Transplant 19:21–28
Stephenne X, Najimi M, Sokal EM (2010) Hepatocyte cryopreservation: is it time to change the strategy? World J Gastroenterol 16:1–14
Terry C, Dhawan A, Mitry RR, Lehec SC, Hughes RD (2010) Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl 16:229–237
McKiernan P (2013) Liver transplantation and cell therapies for inborn errors of metabolism. J Inherit Metab Dis 36(4):675–680
Bin WT, Ma LM, Xu Q, Shi XL (2012) Embryonic hepatocyte transplantation for hepatic cirrhosis: efficacy and mechanism of action. World J Gastroenterol 18:309–322
Cantz T, Zuckerman DM, Burda MR, Dandri M, Goricke B, Thalhammer S et al (2003) Quantitative gene expression analysis reveals transition of fetal liver progenitor cells to mature hepatocytes after transplantation in uPA/RAG-2 mice. Am J Pathol 162:37–45
Habibullah CM, Syed IH, Qamar A, Taher-Uz Z (1994) Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 58:951–952
Khan AA, Habeeb A, Parveen N, Naseem B, Babu RP, Capoor AK, Habibullah CM (2004) Peritoneal transplantation of human fetal hepatocytes for the treatment of acute fatty liver of pregnancy: a case report. Trop Gastroenterol 25:141–143
Meyburg J, Alexandrova K, Barthold M, Kafert-Kasting S, Schneider AS, Attaran M et al (2009) Liver cell transplantation: basic investigations for safe application in infants and small children. Cell Transplant 18:777–786
Meyburg J, Das AM, Hoerster F, Lindner M, Kriegbaum H, Engelmann G et al (2009) One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 87:636–641
Tolosa L, Pareja-Ibars E, Donato MT, Cortes M, Lopez S, Jimenez N et al (2014) Neonatal livers: a source for the isolation of good-performing hepatocytes for cell transplantation. Cell Transplant 23:1229–1242
Chinnici CM, Timoneri F, Amico G, Pietrosi G, Vizzini G, Spada M et al (2015) Characterization of liver-specific functions of human fetal hepatocytes in culture. Cell Transplant 24:1139–1153
Allameh A, Kazemnejad S (2012) Safety evaluation of stem cells used for clinical cell therapy in chronic liver diseases; with emphasize on biochemical markers. Clin Biochem 45:385–396
Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L et al (2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6:1229–1234
Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C et al (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51:297–305
Duan Y, Ma X, Zou W, Wang C, Bahbahan IS, Ahuja TP et al (2010) Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells. Stem Cells 28:674–686
Hannan NR, Segeritz CP, Touboul T, Vallier L (2013) Production of hepatocyte-like cells from human pluripotent stem cells. Nat Protoc 8:430–437
Schwartz RE, Fleming HE, Khetani SR, Bhatia SN (2014) Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv 32:504–513
Enns GM, Millan MT (2008) Cell-based therapies for metabolic liver disease. Mol Genet Metab 95:3–10
Sokal EM (2006) Liver transplantation for inborn errors of liver metabolism. J Inherit Metab Dis 29:426–430
Darwish AA, Sokal E, Stephenne X, Najimi M, de Goyet JV, Reding R (2004) Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl 10:1213–1215
Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, Strom SC, Fox IJ (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262–1267
Ribes-Koninckx C, Pareja Ibars E, Agrasot MA, Bonora-Centelles A, Polo Miquel B, Vila Carbo JJ et al (2012) Clinical outcome of hepatocyte transplantation in four pediatric patients with inherited metabolic diseases. Cell Transplant 21(10):2267–2282
Wan Z, Zhang XG, Liu ZW, Lv Y (2013) Therapeutic liver repopulation for metabolic liver diseases: advances from bench to bedside. Hepatol Res 43:122–130
Raper SE, Grossman M, Rader DJ, Thoene JG, Clark BJ III, Kolansky DM et al (1996) Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg 223:116–126
Bilir BM, Guinette D, Karrer F, Kumpe DA, Krysl J, Stephens J et al (2000) Hepatocyte transplantation in acute liver failure. Liver Transpl 6:32–40
Mito M, Kusano M, Kawaura Y (1992) Hepatocyte transplantation in man. Transplant Proc 24:3052–3053
Bhogal RH, Hodson J, Bartlett DC, Weston CJ, Curbishley SM, Haughton E et al (2011) Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 6:e18222
Yamanaka S (2009) A fresh look at iPS cells. Cell 137:13–17
Gridelli B, Vizzini G, Pietrosi G, Luca A, Spada M, Gruttadauria S et al (2012) Efficient human fetal liver cell isolation protocol based on vascular perfusion for liver cell-based therapy and case report on cell transplantation. Liver Transpl 18:226–237
Hann IM, Bodger MP, Hoffbrand AV (1983) Development of pluripotent hematopoietic progenitor cells in the human fetus. Blood 62:118–123
Roy V, Miller JS, Verfaillie CM (1997) Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Exp Hematol 25:387–394
Migliaccio G, Migliaccio AR, Petti S, Mavilio F, Russo G, Lazzaro D et al (1986) Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac—liver transition. J Clin Invest 78:51–60
Nava S, Westgren M, Jaksch M, Tibell A, Broome U, Ericzon BG, Sumitran-Holgersson S (2005) Characterization of cells in the developing human liver. Differentiation 73:249–260
Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL et al (2007) Human hepatic stem cells from fetal and postnatal donors. J Exp Med 204:1973–1987
Oertel M (2011) Fetal liver cell transplantation as a potential alternative to whole liver transplantation? J Gastroenterol 46:953–965
Hines RN (2007) Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 21:169–175
Hines RN (2012) Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children. Int J Pharm 452(1–2):3–7
Wrighton SA, Vandenbranden M (1989) Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family. Arch Biochem Biophys 268:144–151
McCarver DG, Hines RN (2002) The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 300:361–366
Miyagi SJ, Milne AM, Coughtrie MW, Collier AC (2012) Neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics. Drug Metab Dispos 40:1321–1327
Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, Manns MP (2002) Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:259–265
Weber A, Touboul T, Mainot S, Branger J, Mahieu-Caputo D (2010) Human foetal hepatocytes: isolation, characterization, and transplantation. Methods Mol Biol 640:41–55
Wu Y, Shatapathy CC, Minger SL (2009) Isolation, in vitro cultivation and characterisation of foetal liver cells. Methods Mol Biol 481:181–192
Pietrosi G, Vizzini G, Gerlach J, Chinnici C, Luca A, Amico G et al (2015) Phases I–II matched case-control study of human fetal liver cell transplantation for treatment of chronic liver disease. Cell Transplant 24:1627–1638
Yovchev MI, Xue Y, Shafritz DA, Locker J, Oertel M (2014) Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes. Hepatology 59:284–295
Gomez-Lechon MJ, Castell JV, Donato MT (2008) An update on metabolism studies using human hepatocytes in primary culture. Expert Opin Drug Metab Toxicol 4:837–854
Blake MJ, Castro L, Leeder JS, Kearns GL (2005) Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 10:123–138
Johnson TN (2003) The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 192:37–48
Schmelzer E, Wauthier E, Reid LM (2006) The phenotypes of pluripotent human hepatic progenitors. Stem Cells 24:1852–1858
Zhang L, Theise N, Chua M, Reid LM (2008) The stem cell niche of human livers: symmetry between development and regeneration. Hepatology 48:1598–1607
Gentric G, Desdouets C, Celton-Morizur S (2012) Hepatocytes polyploidization and cell cycle control in liver physiopathology. Int J Hepatol 2012:282430
Celton-Morizur S, Desdouets C (2010) Polyploidization of liver cells. Adv Exp Med Biol 676:123–135
Stephenne X, Najimi M, Ngoc DK, Smets F, Hue L, Guigas B, Sokal EM (2007) Cryopreservation of human hepatocytes alters the mitochondrial respiratory chain complex 1. Cell Transplant 16:409–419
Pinkse GG, Voorhoeve MP, Noteborn M, Terpstra OT, Bruijn JA, De Heer E (2004) Hepatocyte survival depends on beta1-integrin-mediated attachment of hepatocytes to hepatic extracellular matrix. Liver Int 24:218–226
Brilliant KE, Mills DR, Callanan HM, Hixson DC (2009) Engraftment of syngeneic and allogeneic endothelial cells, hepatocytes and cholangiocytes into partially hepatectomized rats previously treated with mitomycin C. Transplantation 88:486–495
Cusick RA, Lee H, Sano K, Pollok JM, Utsunomiya H, Ma PX et al (1997) The effect of donor and recipient age on engraftment of tissue-engineered liver. J Pediatr Surg 32:357–360
Suzuki A, Taniguchi H, Zheng YW, Takada Y, Fukunaga K, Seino K et al (2000) Proliferative and functional ability of transplanted murine neonatal hepatocytes in adult livers. Transplant Proc 32:2370–2371
Alison MR, Choong C, Lim S (2007) Application of liver stem cells for cell therapy. Semin Cell Dev Biol 18:819–826
Haridass D, Narain N, Ott M (2008) Hepatocyte transplantation: waiting for stem cells. Curr Opin Organ Transplant 13:627–632
Lysy PA, Campard D, Smets F, Najimi M, Sokal EM (2008) Stem cells for liver tissue repair: current knowledge and perspectives. World J Gastroenterol 14:864–875
Wobus AM, Boheler KR (2005) Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85:635–678
Agarwal S, Holton KL, Lanza R (2008) Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 26:1117–1127
Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H et al (2007) Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 45:1229–1239
Baxter MA, Rowe C, Alder J, Harrison S, Hanley KP, Park BK et al (2010) Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res 5:4–22
Takayama K, Kawabata K, Nagamoto Y, Kishimoto K, Tashiro K, Sakurai F et al (2013) 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials 34:1781–1789
Hay DC, Fletcher J, Payne C, Terrace JD, Gallagher RC, Snoeys J et al (2008) Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A 105:12301–12306
Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78:7634–7638
Ben-David U, Benvenisty N (2011) The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11:268–277
Cui L, Shi Y, Zhou X, Wang X, Wang J, Lan Y et al (2013) A set of microRNAs mediate direct conversion of human umbilical cord lining-derived mesenchymal stem cells into hepatocytes. Cell Death Dis 4:e918
Chinzei R, Tanaka Y, Shimizu-Saito K, Hara Y, Kakinuma S, Watanabe M et al (2002) Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 36:22–29
Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L et al (2009) Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6:e1000029
Harding J, Mirochnitchenko O (2014) Preclinical studies for induced pluripotent stem cell-based therapeutics. J Biol Chem 289:4585–4593
Tan Y, Ooi S, Wang L (2014) Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectives. Curr Stem Cell Res Ther 9:63–72
Kondo Y, Iwao T, Nakamura K, Sasaki T, Takahashi S, Kamada N et al (2014) An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity. Drug Metab Pharmacokinet 29:237–243
Baxter M, Withey S, Harrison S, Segeritz CP, Zhang F, Atkinson-Dell R et al (2015) Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol 62:581–589
Gieseck RL III, Hannan NR, Bort R, Hanley NA, Drake RA, Cameron GW et al (2014) Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS One 9:e86372
Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T et al (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499:481–484
Dianat N, Steichen C, Vallier L, Weber A, Dubart-Kupperschmitt A (2013) Human pluripotent stem cells for modelling human liver diseases and cell therapy. Curr Gene Ther 13:120–132
Choi SM, Kim Y, Liu H, Chaudhari P, Ye Z, Jang YY (2011) Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells. Cell Cycle 10:2423–2427
Zhao T, Zhang ZN, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474:212–215
Vallier L (2014) Heps with pep: direct reprogramming into human hepatocytes. Cell Stem Cell 14:267–269
Du Y, Wang J, Jia J, Song N, Xiang C, Xu J et al (2014) Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell 14:394–403
Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z et al (2014) Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 14:370–384
Fausto N, Campbell JS, Riehle KJ (2006) Liver regeneration. Hepatology 43:S45–S53
Michalopoulos GK, DeFrances MC (1997) Liver regeneration. Science 276:60–66
Fausto N, Campbell JS (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120:117–130
Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM et al (2015) Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160:299–312
Tarlow BD, Pelz C, Naugler WE, Wakefield L, Wilson EM, Finegold MJ, Grompe M (2014) Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 15:605–618
Yanger K, Knigin D, Zong Y, Maggs L, Gu G, Akiyama H et al (2014) Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell 15:340–349
Shin S, Upadhyay N, Greenbaum LE, Kaestner KH (2015) Ablation of Foxl1-Cre-labeled hepatic progenitor cells and their descendants impairs recovery of mice from liver injury. Gastroenterology 148(192–202):e193
Habeeb MA, Vishwakarma SK, Bardia A, Khan AA (2015) Hepatic stem cells: a viable approach for the treatment of liver cirrhosis. World J Stem Cells 7:859–865
Rao MS, Khan AA, Parveen N, Habeeb MA, Habibullah CM, Pande G (2008) Characterization of hepatic progenitors from human fetal liver during second trimester. World J Gastroenterol 14:5730–5737
Lysy PA, Campard D, Smets F, Malaise J, Mourad M, Najimi M, Sokal EM (2008) Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells. Cell Prolif 41:36–58
Seo MJ, Suh SY, Bae YC, Jung JS (2005) Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 328:258–264
Duncan SA (2003) Mechanisms controlling early development of the liver. Mech Dev 120:19–33
Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M et al (2009) Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 24:70–77
Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G et al (2007) Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46:219–228
Bonora-Centelles A, Jover R, Mirabet V, Lahoz A, Carbonell F, Castell JV, Gomez-Lechon MJ (2009) Sequential hepatogenic transdifferentiation of adipose tissue-derived stem cells: relevance of different extracellular signaling molecules, transcription factors involved, and expression of new key marker genes. Cell Transplant 18:1319–1340
Snykers S, Vanhaecke T, Papeleu P, Luttun A, Jiang Y, Vander Heyden Y et al (2006) Sequential exposure to cytokines reflecting embryogenesis: the key for in vitro differentiation of adult bone marrow stem cells into functional hepatocyte-like cells. Toxicol Sci 94:330–341, discussion 235–339
Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC et al (2008) Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134:2111–2121
Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, Yarmush ML (2009) Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A 15:3377–3388
Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M et al (2008) IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 26:2705–2712
Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U (2007) Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77:577–588
Miki T, Marongiu F, Ellis EC, Dorko K, Mitamura K, Ranade A et al (2009) Production of hepatocyte-like cells from human amnion. Methods Mol Biol 481:155–168
Marongiu F, Gramignoli R, Dorko K, Miki T, Ranade AR, Paola Serra M et al (2011) Hepatic differentiation of amniotic epithelial cells. Hepatology 53:1719–1729
Vaghjiani V, Vaithilingam V, Saraswati I, Sali A, Murthi P, Kalionis B et al (2014) Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro. Stem Cells Dev 23:866–876
Strom SC, Skvorak K, Gramignoli R, Marongiu F, Miki T (2013) Translation of amnion stem cells to the clinic. Stem Cells Dev 22(Suppl 1):96–102
Donato MT, Lahoz A, Montero S, Bonora A, Pareja E, Mir J et al (2008) Functional assessment of the quality of human hepatocyte preparations for cell transplantation. Cell Transplant 17:1211–1219
Gramignoli R, Tahan V, Dorko K, Venkataramanan R, Fox IJ, Ellis EC et al (2014) Rapid and sensitive assessment of human hepatocyte functions. Cell Transplant 23:1545–1556
Aoki T, Koizumi T, Kobayashi Y, Yasuda D, Izumida Y, Jin Z et al (2005) A novel method of cryopreservation of rat and human hepatocytes by using encapsulation technique and possible use for cell transplantation. Cell Transplant 14:609–620
Kusano T, Aoki T, Yasuda D, Matsumoto S, Jin Z, Nishino N et al (2008) Microencapsule technique protects hepatocytes from cryoinjury. Hepatol Res 38:593–600
Jitraruch S, Dhawan A, Hughes RD, Filippi C, Soong D, Philippeos C et al (2014) Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure. PLoS One 9:e113609
Sgroi A, Mai G, Morel P, Baertschiger RM, Gonelle-Gispert C, Serre-Beinier V, Buhler LH (2011) Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration. Cell Transplant 20:1791–1803
Cantz T, Sharma AD, Ott M (2015) Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments. Stem Cells 33:1055–1062
Kadyk LC, Collins LR, Littman NJ, Millan MT (2015) Proceedings: moving toward cell-based therapies for liver disease. Stem Cells Transl Med 4:207–210
Tuchman M, Caldovic L, Daikhin Y, Horyn O, Nissim I, Korson M et al (2008) N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers. Pediatr Res 64:213–217
Najimi M, Khuu DN, Lysy PA, Jazouli N, Abarca J, Sempoux C, Sokal EM (2007) Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 16:717–728
Sokal EM, Stephenne X, Ottolenghi C, Jazouli N, Clapuyt P, Lacaille F (2014) Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency. JIMD Rep 13:65–72
Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA et al (2010) Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant 19:409–418
Lanzoni G, Oikawa T, Wang Y, Cui CB, Carpino G, Cardinale V et al (2013) Concise review: clinical programs of stem cell therapies for liver and pancreas. Stem Cells 31:2047–2060
Margini C, Vukotic R, Brodosi L, Bernardi M, Andreone P (2014) Bone marrow derived stem cells for the treatment of end-stage liver disease. World J Gastroenterol 20:9098–9105
Meier RP, Muller YD, Morel P, Gonelle-Gispert C, Buhler LH (2013) Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res 11:1348–1364
Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N et al (2007) Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 13:3359–3363
Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, Levicar N et al (2008) Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 103:1952–1958
Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C et al (2011) Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 54:820–828
Xu L, Gong Y, Wang B, Shi K, Hou Y, Wang L et al (2014) Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells. J Gastroenterol Hepatol 29:1620–1628
Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI et al (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338:1422–1426
Ambrosino G, Varotto S, Strom SC, Guariso G, Franchin E, Miotto D et al (2005) Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant 14:151–157
Dhawan A, Mitry RR, Hughes RD (2006) Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 29:431–435
Lysy PA, Najimi M, Stephenne X, Bourgois A, Smets F, Sokal EM (2008) Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. World J Gastroenterol 14:3464–3470
Allen KJ, Mifsud NA, Williamson R, Bertolino P, Hardikar W (2008) Cell-mediated rejection results in allograft loss after liver cell transplantation. Liver Transpl 14:688–694
Meyburg J, Hoerster F, Schmidt J, Poeschl J, Hoffmann GF, Schenk JP (2010) Monitoring of intraportal liver cell application in children. Cell Transplant 19:629–638
Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, Posner MP (1997) Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63:559–569
Puppi J, Tan N, Mitry RR, Hughes RD, Lehec S, Mieli-Vergani G et al (2008) Hepatocyte transplantation followed by auxiliary liver transplantation—a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant 8:452–457
Stephenne X, Najimi M, Smets F, Reding R, de Ville de Goyet J, Sokal EM (2005) Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 5:2058–2061
Fisher RA, Bu D, Thompson M, Tisnado J, Prasad U, Sterling R et al (2000) Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion. Transplantation 69:303–307
Stephenne X, Najimi M, Sibille C, Nassogne MC, Smets F, Sokal EM (2006) Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 130:1317–1323
Muraca M, Burlina AB (2005) Liver and liver cell transplantation for glycogen storage disease type IA. Acta Gastroenterol Belg 68:469–472
Lee KW, Lee JH, Shin SW, Kim SJ, Joh JW, Lee DH et al (2007) Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant 16:629–637
Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R et al (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76:735–738
Stephenne X, Debray FG, Smets F, Jazouli N, Sana G, Tondreau T, Menten R et al (2012) Hepatocyte transplantation using the domino concept in a child with tetrabiopterin nonresponsive phenylketonuria. Cell Transplant 21:2765–2770
Beck BB, Habbig S, Dittrich K, Stippel D, Kaul I, Koerber F et al (2012) Liver cell transplantation in severe infantile oxalosis—a potential bridging procedure to orthotopic liver transplantation? Nephrol Dial Transplant 27:2984–2989
Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ III et al (1995) A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1:1148–1154
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Pareja, E., Gómez-Lechón, M.J., Tolosa, L. (2017). Alternative Cell Sources to Adult Hepatocytes for Hepatic Cell Therapy. In: Stock, P., Christ, B. (eds) Hepatocyte Transplantation. Methods in Molecular Biology, vol 1506. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6506-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6506-9_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6504-5
Online ISBN: 978-1-4939-6506-9
eBook Packages: Springer Protocols